Carl M. Sutherland

2.1k total citations
42 papers, 1.4k citations indexed

About

Carl M. Sutherland is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Carl M. Sutherland has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Carl M. Sutherland's work include Cutaneous Melanoma Detection and Management (13 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Carl M. Sutherland is often cited by papers focused on Cutaneous Melanoma Detection and Management (13 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Carl M. Sutherland collaborates with scholars based in United States, Tanzania and Australia. Carl M. Sutherland's co-authors include Edward T. Krementz, Carol Redmond, Frances J. Mather, Norman Wolmark, N V Dimitrov, David M. J. S. Bowman, James H. Muchmore, Marilyn S. Campbell, Edwin R. Fisher and R Margolese and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Carl M. Sutherland

42 papers receiving 1.3k citations

Peers

Countries citing papers authored by Carl M. Sutherland

Since Specialization

Citations

This map shows the geographic impact of Carl M. Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl M. Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl M. Sutherland more than expected).

Fields of papers citing papers by Carl M. Sutherland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl M. Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl M. Sutherland. The network helps show where Carl M. Sutherland may publish in the future.

Co-authorship network of co-authors of Carl M. Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of Carl M. Sutherland. A scholar is included among the top collaborators of Carl M. Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl M. Sutherland. Carl M. Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. 1996 ·Journal of Clinical Oncology ·Bernard Fisher, James J. Dignam, Eleftherios P. Mamounas, Joseph P. Costantino, D. Lawrence Wickerham, Carol Redmond, Norman Wolmark, N V Dimitrov, David M. J. S. Bowman, Andrew G. Glass, J. N. Atkins, Neil Abramson, Carl M. Sutherland, Bernard S. Aron, Richard G. Margolese	175
2	ISOLATED HYPERTHERMIA CHEMOTHERAPY PERFUSION FOR LIMB MELANOMA 1996 ·Surgical Clinics of North America ·Edward T. Krementz, Carl M. Sutherland, James H. Muchmore	19
3	Regional Chemotherapy for Melanoma A 35-Year Experience 1994 ·Annals of Surgery ·Edward T. Krementz, (unknown), Carl M. Sutherland, James H. Muchmore, Robert F. Ryan, Oscar Creech	53
4	Prognostic evaluation of intracranial metastasis in malignant melanoma 1994 ·Annals of Surgical Oncology ·Sukamal Saha, (unknown), Edward T. Krementz, Syed A. Hoda, (unknown), James H. Muchmore, Carl M. Sutherland	37
5	Acral lentiginous melanoma 1993 ·The American Journal of Surgery ·Carl M. Sutherland, Frances J. Mather, James H. Muchmore, (unknown), Richard J. Reed, Edward T. Krementz	42
6	Concordant Uptake of Tc-99m Sestamibi and TI-201 in Unsuspected Breast Tumor 1992 ·Clinical Nuclear Medicine ·Richard J. Campeau, (unknown), Carl M. Sutherland	37
7	Evaluation of the worth ofCorynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer: Eight-year results from the national surgical adjuvant breast and bowel project B-10 1990 ·Cancer ·Bernard Fisher, Ann Brown, Norman Wolmark, Edwin R. Fisher, Carol Redmond, D. Lawrence Wickerham, Richard G. Margolese, Nikolay Dimitrov, Yosef H. Pilch, Andrew G. Glass, Carl M. Sutherland, Roger S. Foster	26
8	A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative Tumors 1989 ·New England Journal of Medicine ·B. Fisher, Carol Redmond, N V Dimitrov, David M. J. S. Bowman, S Legault-Poisson, D. L. Wickerham, Norman Wolmark, Edwin R. Fisher, R Margolese, Carl M. Sutherland, (unknown), (unknown), (unknown)	305
9	Carcinoid Tumors of the Gastrointestinal Tract 1989 ·Southern Medical Journal ·Sukamal Saha, Syed A. Hoda, Richard Godfrey, Carl M. Sutherland, (unknown)	82
10	Panel II: Liability issues 1989 ·Cancer ·Carl M. Sutherland, (unknown)	1
11	Charity Hospital Experience with Long-term Survival and Prognostic Factors in Patients with Breast Cancer with Localized or Regional Disease 1988 ·Annals of Surgery ·Carl M. Sutherland, Frances J. Mather	11
12	Breast neoplasms: duplex sonographic imaging as an adjunct in diagnosis. 1988 ·Radiology ·(unknown), Carl M. Sutherland, Ann E. Robinson	65
13	Isolated Perfusion of Extremities for Metastatic Melanoma From an Unknown Primary Lesion 1986 ·Southern Medical Journal ·James H. Muchmore, Edward T. Krementz, (unknown), Carl M. Sutherland, (unknown)	8
14	Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes 1986 ·Cancer ·Carl M. Sutherland, Frances J. Mather	22
15	Serological Detection of Common Human Melanoma Membrane Antigens by Microcomplement Fixation and Immunofluorescence 1983 ·Oncology ·Stanley P. L. Leong, Sidney R. Cooperband, Peter J. Deckers, Carl M. Sutherland, (unknown), Edward T. Krementz	2
16	Chemotherapy of Germ Cell Tumors in Women 1982 ·Archives of Internal Medicine ·Carl M. Sutherland	2
17	Recurrence of Neuroblastoma Following Prolonged Remission 1981 ·Archives of Surgery ·Carl M. Sutherland	3
18	The use of regional chemotherapy in the management of malignant melanoma 1979 ·World Journal of Surgery ·Edward T. Krementz, (unknown), Carl M. Sutherland, Marilyn S. Campbell	55
19	Common human melanoma membrane antigens detected by mixed hemadsorption microassay with serum from a patient undergoing immunotherapy with autologous tumor cells. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Shuen‐Kuei Liao, Stanley P. L. Leong, Carl M. Sutherland, Peter B. Dent, Pak C. Kwong, Edward T. Krementz	20
20	Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Stanley P. L. Leong, Carl M. Sutherland, Edward T. Krementz	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact